JavaScript is off. Please enable to view full site.

World Health Orgnization representative on Nano Covax’s request for emergency use in Vietnam

World Health Orgnization representative on Nano Covax’s request for emergency use in Vietnam

Wednesday, June 30, 2021, 15:39 GMT+7
World Health Orgnization representative on Nano Covax’s request for emergency use in Vietnam
Dr Park Ki-dong – WHO Representative in Vietnam. Photo courtesy of WHO

A World Health Organization (WHO) representative has underlined the responsibility of vaccine producers’ in upholding data transparency as a domestic company is urging the government to approve its jab for emergency use in Vietnam without finishing late-stage clinical trials.

Dr. Park Ki-dong – WHO Representative in Vietnam – sat down for an interview with Tuoi Tre News on Tuesday, at a time when Ho Chi Minh City was implementing its biggest-ever vaccination drive to contain a major COVID-19 resurgence that has been ongoing since late April. 

Vietnam has documented over 13,000 local infections in 50 out of its 63 provinces and cities since April 27, when the pandemic's fourth wave erupted, including more than 3,700 cases in the business hub Ho Chi Minh City.

These figures are multiple times those recorded in the previous rounds. The country now adds hundreds of patients on a daily basis.

On the request of Nanogen Pharmaceutical Biotechnology JSC, a local company, for the Vietnamese Ministry of Health's approval of its Nano Covax vaccine for emergency use, Dr. Park warned authorities to review related data carefully to align with national regulations and legislation.

He also aired opinions on Ho Chi Minh City’s recent measures to combat COVID-19, emphasizing that vaccine is not a silver bullet.

Regarding the request to validate Vietnam’s homegrown COVID-19 vaccine Nano Covax for emergency use, the Ministry of Health thinks that it is "hasty, as there is not enough scientific data.'' What is the opinion of WHO about this statement? What conditions must be met for a vaccine to be approved for emergency use?

To date, a number of COVID-19 vaccine products have already been approved for WHO emergency use listing and used in mass vaccinations in many countries.

However, the speed of development does not mean that these vaccines were approved by skipping essential steps of testing and evaluation. 

Any vaccine should go through a rigorous evaluation process of efficacy, quality, and safety through multiple steps of assessment including pre-clinical assessment and three phases of clinical trials. 

Even for emergency use approval such as for COVID-19 vaccine, all critical steps and necessary criteria should not be skipped. 

As of June 25, 2021, 184 vaccines are under pre-clinical development and another 104 vaccines are under clinical assessment stage of development globally.

We understand Nano Covax has just entered clinical trial phase 3. In principle, the manufacturer should generate sufficient scientific data on efficacy, quality, and safety from these clinical trials. The national regulatory authority should review the data carefully once available, in line with the national regulations and legislation.

To support manufacturers and national regulatory authorities in this unprecedented situation, WHO has published documents and guides on clinical evaluation and evaluation standards for COVID-19 vaccines that governments can use as the basis for their own regulatory guidelines.

Currently, some countries around the world, for example Cuba, have administered new vaccine shots in large-scale phase 3 trials as part of their intervention studies on how effective they are in preventing and stopping the spread of the respiratory disease. What should be noted if Vietnam wants to apply similar measures to its domestic COVID-19 vaccines?

The clinical trial phase 3 is usually done on a large scale with more than several thousand participants at multiple study centers before vaccine usage by the public. The study design should be well-developed, reviewed, and approved by a research ethics committee as well as the National Regulatory Authority (NRA) of the country where the trial is conducted.

For COVID-19 vaccines, there are instances where a country may decide on some exceptional ways to address the unprecedented need to control the disease. However, alternative options should be based on careful risk and benefit assessment in the country, and be carefully planned with ethical considerations together with risk management. They should not compromise the critical requirements and evaluation criteria to ensure the safety, quality, and efficacy of a vaccine.

The COVID-19 situation in Ho Chi Minh City is getting complicated. What are WHO’s recommendations for the city to curb the pandemic?

Vaccines could be an effective tool to fight this pandemic in the long run. But the role of vaccines in acute outbreak control settings is limited. Most vaccines require two shots and a few weeks after the second shot to protect people. Social distancing, combined with vaccine, is the right approach.

The Vietnamese government has been working proactively together with international partners to secure more vaccines for the country and to ensure its equitable access to everyone.

The government has reinforced the robust outbreak response actions that have proven to work. These include the four-on-the-spot approach (human resources – facilities – response actions – resources) and five-principle strategy (prevention – early detection – quarantine – zoning – stamping out outbreaks).

We understand that the Ho Chi Minh City People’s Committee has directed the health system to increase the testing capacity up to 500,000 samples per day and health workers have been working round the clock. The committee has been decisive in directing public health measures, including the issuance of its own Directive No. 10 to guide social distancing measures to be applied. We need our people to once again show solidarity and compliance to health measures.

Nano Covax vaccine’s development and approval request 

COVID-19 vaccine Nano Covax by Nanogen Pharmaceutical Biotechnology JSC officially entered clinical trial phase 3 on June 11. 

The vaccine has been developed based on recombinant proteins technology since May last year. 

On June 22, Nanogen stated that it had filed a request to the prime minister asking to validate Nano Covax for emergency use. On the same day, Nguyen Ngo Quang – deputy head of the Bureau of Science, Technology, and Training under the Ministry of Health – told Tuoi Tre that the request was “hasty, as there is not enough scientific data." 

In response, a Nanogen representative told Tuoi Tre on June 23 that “the company faces difficulties in dealing with mechanisms of ‘requesting and granting (licenses)’ during the process of researching, experimenting and validating through the development phases of Nano Covax vaccine." 

“It is costly for us to invest in researching, producing, and experimenting with a global-scale vaccine.

"Meanwhile, authorities say they will only validate [Nano Covax for emergency use] if there is a vaccine shortage, otherwise, it won’t be licensed.

"It is not inconsequential."

On June 26, Prime Minister Pham Minh Chinh led the government’s task force to work with Nanogen.

He emphasized Vietnam’s three-plan vaccine strategy including accelerating vaccine procurement, receiving transferred vaccine technology, and manufacturing homegrown jabs. 

“Vaccines play a decisive role in the fight against the pandemic," said PM Chính said. 

"Countries which effectively roll out vaccination will soon obtain normalcy.”

Like us on Facebook or follow us on Twitter to get the latest news about Vietnam!

Khoa Thu / Tuoi Tre News


Read more




‘Taste of Australia’ gala dinner held in Ho Chi Minh City after 2-year hiatus

Taste of Australia Gala Reception has returned to the Park Hyatt Hotel in Ho Chi Minh City's District 1 after a two-year hiatus due to the COVID-19 pandemic

Vietnamese woman gives unconditional love to hundreds of adopted children

Despite her own immense hardship, she has taken in and cared for hundreds of orphans over the past three decades.

Vietnam’s Mekong Delta celebrates spring with ‘hat boi’ performances

The art form is so popular that it attracts people from all ages in the Mekong Delta

Vietnamese youngster travels back in time with clay miniatures

Each work is a scene caught by Dung and kept in his memories through his journeys across Vietnam

Latest news